Skip to content Skip to sidebar Skip to footer

Low Plasma Gelsolin Fuels Therapy Resistance in ESCC

Introduction Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive forms of esophageal cancer and often presents treatment challenges due to its resistance to chemoradiotherapy (CRT). A recent study titled "Decreased plasma gelsolin fosters a fibrotic tumor microenvironment and promotes chemoradiotherapy resistance in esophageal squamous cell carcinoma" sheds light on an intriguing factor…

Read More

Unraveling the Immune Landscape of Colorectal Cancer: Tumor Specificity vs Bystander Activity in CD8+ T Cells

Colorectal cancer (CRC), a formidable foe in the global fight against cancer, presents a complex puzzle to scientists. While strides have been made in understanding the underlying genetics, the intricate interplay between tumor cells and the immune system remains a mystery. At the heart of this battleground lie CD8+ T cells, immune system warriors crucial…

Read More